Table 1.

Description of study cohorts, only aging population.

Name	Data source/owner	Original collection criteria (nationality)	Total included sample size (% women)	Death events in the follow-up period	Age at the beginning of 10-year mortality follow-up	Cohort description	Purpose
National FINRISK study	THL Biobank	Random population sample (FIN)	20,078 (52%)	2,389 (12%)	60 (53–67)	Borodulin et al.11	Primary derivation and evaluation set
Health 2000 study	THL Biobank	Random population sample (FIN)	5,410 (55%)	1,082 (20%)	61 (54–72)	Heistaro et al.12	External validation (different subset of medications)
Estonian biobank	University of Tartu	Random population sample (EST)	28,206 (68%)	2,517 (8.9%)	61 (53–71)	Leitsalu et al.13	External validation (different timeframe)

Data are n (%) or median (IQR).